Mary F Malley Selected Research

BMS 189664

1/2002

Molecular design and structure--activity relationships leading to the potent, selective, and orally active thrombin active site inhibitor BMS-189664.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mary F Malley Research Topics

Disease

2	Obesity 01/2011 - 03/2007
1	Body Weight (Weight, Body) 03/2007
1	Type 2 Diabetes Mellitus (MODY) 05/2004
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2002

Drug/Important Bio-Agent (IBA)

2	Pharmaceutical PreparationsIBA 01/2011 - 03/2007
1	CannabinoidsIBA 01/2011
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2011
1	Serotonin 5-HT2 Receptor AntagonistsIBA 03/2007
1	Glucagon-Like Peptide 1 (GLP 1)IBA 05/2004
1	Glucose (Dextrose)FDA LinkGeneric 05/2004
1	BMS 189664IBA 01/2002
1	Thrombin FDA Link 01/2002

Therapy/Procedure

1	Therapeutics 03/2007